Imaging technology plays an integral role in cardiovascular disease research. Ace Therapeutics can provide preclinical imaging services for experimental animals to help researchers detect cardiovascular disease states and evaluate drug efficiency.
Imaging technology helps to assess the health of the cardiovascular system by presenting the structure and density of animal tissues and organs in the form of images using specific media such as X-rays, electromagnetic fields and ultrasound.
| Imaging Technologies | Applications in Cardiovascular Diseases | |
|---|---|---|
| X-ray | Computed Radiography (CR) |
|
| Digital Radiography (DR) | ||
| Computerized Tomography (CT) | ||
| Ultrasonography | B-scan Ultrasonography |
|
| Color Ultrasonography | ||
| Nuclear Magnetic Resonance (NMR) |
|
|
| Nuclear Medicine | Positron Emission Tomography (PET) |
|
| Single Photon Emission Computed Tomography (SPECT) | ||
Ace Therapeutics has a well-developed imaging technology platform that can provide customers with appropriate cardiovascular disease imaging services and help them further advance their cardiovascular disease research.
We can use luciferase gene labeling or fluorescent reporter group labeling methods to allow researchers to directly monitor cellular activity and gene behavior in living laboratory animals.
We are able to provide ECG monitoring and analysis services for various common experimental animals to help researchers carry out related cardiovascular disease studies.
We can provide echocardiography services for animal models of cardiovascular disease research to help researchers understand the functional status of the heart and great vessels in experimental animals.
We are able to provide computed tomography testing services for common laboratory animals to help researchers better observe the structure of the cardiovascular system of laboratory animals.
We are able to provide MRI services for common laboratory animals to help researchers obtain images of experimental animal organs and tissues to support disease monitoring and drug discovery experiments.
We can offer radionuclide imaging services for common experimental animals, providing researchers with visualization of myocardial perfusion and myocardial infarction visualization results.
We offer a variety of AI-based cardiovascular imaging analysis services that can automatically analyze a wide range of complex pathology imaging results.
Ace Therapeutics is a contract research organization dedicated to providing cardiovascular disease research services. We are striving to contribute to the field of cardiovascular disease research by providing high quality imaging research solutions to researchers in the field of cardiovascular disease. If you are interested in our preclinical imaging services for cardiovascular diseases, please do not hesitate to contact us.
Ace Therapeutics offers comprehensive solutions and R&D services to researchers worldwide to advance the field of cardiovascular diseases.
We do not provide medical care for patients.
Copyright © Ace Therapeutics. All rights reserved.